As of 2026-04-03, the EV/EBITDA ratio of Gennex Laboratories Ltd (531739.BO) is 11.01. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 531739.BO's latest enterprise value is 3,176.94 mil INR. 531739.BO's TTM EBITDA according to its financial statements is 288.53 mil INR. Dividing these 2 quantities gives us the above 531739.BO EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 9.6x - 11.3x | 10.6x |
| Forward P/E multiples | 6.8x - 8.5x | 7.2x |
| Fair Price | 8.03 - 11.23 | 9.22 |
| Upside | -14.7% - 19.3% | -2.1% |
| Date | EV/EBITDA |
| 2026-03-27 | 9.58 |
| 2026-03-25 | 10.04 |
| 2026-03-24 | 10.13 |
| 2026-03-23 | 9.98 |
| 2026-03-20 | 11.00 |
| 2026-03-19 | 10.99 |
| 2026-03-18 | 11.09 |
| 2026-03-17 | 11.09 |
| 2026-03-16 | 10.89 |
| 2026-03-13 | 11.49 |
| 2026-03-12 | 11.60 |
| 2026-03-11 | 11.81 |
| 2026-03-10 | 11.61 |
| 2026-03-09 | 12.02 |
| 2026-03-06 | 12.62 |
| 2026-03-05 | 13.10 |
| 2026-03-04 | 12.42 |
| 2026-03-02 | 12.63 |
| 2026-02-27 | 12.94 |
| 2026-02-26 | 12.74 |
| 2026-02-25 | 12.84 |
| 2026-02-24 | 13.25 |
| 2026-02-23 | 13.43 |
| 2026-02-20 | 13.31 |
| 2026-02-19 | 13.66 |
| 2026-02-18 | 13.49 |
| 2026-02-17 | 13.53 |
| 2026-02-16 | 13.54 |
| 2026-02-13 | 14.03 |
| 2026-02-12 | 13.86 |
| 2026-02-11 | 14.20 |
| 2026-02-10 | 14.26 |
| 2026-02-09 | 14.10 |
| 2026-02-06 | 13.81 |
| 2026-02-05 | 13.95 |
| 2026-02-04 | 14.14 |
| 2026-02-03 | 13.99 |
| 2026-02-02 | 14.00 |
| 2026-02-01 | 14.34 |
| 2026-01-30 | 13.94 |
| 2026-01-29 | 13.86 |
| 2026-01-28 | 13.77 |
| 2026-01-27 | 13.66 |
| 2026-01-23 | 14.37 |
| 2026-01-22 | 14.39 |
| 2026-01-21 | 14.84 |
| 2026-01-20 | 14.68 |
| 2026-01-19 | 14.69 |
| 2026-01-16 | 14.79 |
| 2026-01-14 | 15.33 |